Sarepta Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SRPT Nasdaq 2830 www.sarepta.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sarepta Therapeutics, Inc.

Sarepta's Q2 Earnings & Sales Beat Estimates, '26 Outlook Updated - Aug 6th, 2026 12:05 pm
Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says - Aug 6th, 2026 11:59 am
Sarepta Therapeutics Inc (SRPT) (Q2 2026) Earnings Call Highlights: Strong Profitability and ... - Aug 5th, 2026 11:11 pm
Sarepta Therapeutics Q2 Earnings Call Highlights - Aug 5th, 2026 11:03 pm
Sarepta Therapeutics, Inc. Q2 2026 Earnings Call Summary - Aug 5th, 2026 7:45 pm
Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates - Aug 5th, 2026 6:35 pm
Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics - Aug 5th, 2026 6:30 pm
Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - Aug 5th, 2026 2:05 pm
Arrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ... - Aug 4th, 2026 11:05 pm
Sarepta Therapeutics (SRPT) Names A New CEO, Is The Stock Cheap? - Aug 1st, 2026 4:10 am
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth - Jul 31st, 2026 8:00 am
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 29th, 2026 3:00 pm
Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline - Jul 29th, 2026 8:00 am
Leadership changes afoot at two CGT biotechs - Jul 28th, 2026 9:35 am
Morgan Stanley Views Sarepta CEO Transition As A ‘Positive’ – So, Why Is It Cautious On SRPT Stock In The Near Term? - Jul 27th, 2026 10:33 am
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer - Jul 27th, 2026 6:30 am
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO - Jul 27th, 2026 4:16 am
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company? - Jul 23rd, 2026 9:00 am
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat? - Jul 22nd, 2026 7:25 am
Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results - Jul 22nd, 2026 6:30 am